Home

NORMAN C SELBY

CIK 1192613 · last filed 2022-06-16

NORMAN C SELBY is a corporate insider who has filed 20 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for INFI, was dated Jun 16, 2022. 20 SEC filings were submitted jointly with MILLENNIUM PHARMACEUTICALS INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

20

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
205 WOOD ROAD
MT. KISCO, NY 10549
Related Filers
MILLENNIUM PHARMACEUTICALS INC — 20 joint filings, latest 2008-05-15
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Director 15,000 $0.04 $670 $0 16 2022-06-16
MILLENNIUM PHARMACEUTICALS INC (MLNM) Delisted Director 0 — — $0 4 2008-05-15

Recent Filings

20 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2022-06-16 INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Grant (A) — $0 EDGAR
2021-06-11 INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Grant (A) — $0 EDGAR
2021-05-18 INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Exer (M) +5,000 $4.6K EDGAR
2020-06-18 INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Grant (A) — $0 EDGAR
2019-06-14 INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Grant (A) — $0 EDGAR
2018-06-14 INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Grant (A) — $0 EDGAR
2017-05-26 INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Grant (A) — $0 EDGAR
2017-01-09 INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Grant (A) — $0 EDGAR
2016-06-21 INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Grant (A) — $0 EDGAR
2015-06-16 INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 20
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.